P

Inventor

GREEN MICHAEL ERIC

US21 patents
⚠️ This page may combine multiple inventors who share the name “GREEN MICHAEL ERIC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PFIZER

20 patents
US9527831B2Dec 27, 2016

Heteroaromatic compounds and their use as dopamine D1 ligands

PFIZER13 citations92
US9139561B2Sep 22, 2015

Heteroaromatic compounds and their use as dopamine D1 ligands

PFIZER8 citations92
US9107923B2Aug 18, 2015

Heteroaromatic compounds and their use as dopamine D1 ligands

PFIZER11 citations92
US10093655B2Oct 9, 2018

Heteroaromatic compounds and their use as dopamine D1 ligands

PFIZER3 citations83
US9822097B2Nov 21, 2017

Heteroaromatic compounds and their use as dopamine D1 ligands

PFIZER6 citations83
US8916564B2Dec 23, 2014

Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders

PFIZER6 citations82
US9504669B2Nov 29, 2016

Spliceostatin analogs and methods for their preparation

PFIZER5 citations80
US9169264B2Oct 27, 2015

Spliceostatin analogs and methods for their preparation

PFIZER8 citations80
US9540352B2Jan 10, 2017

Substituted 1,7-naphthyridines as dopamine D1 ligands

PFIZER5 citations73
US10421744B2Sep 24, 2019

Heteroaromatic compounds and their use as dopamine D1 ligands

PFIZER2 citations72
US11964961B2Apr 23, 2024

Heteroaromatic compounds and their use as dopamine D1 ligands

PFIZER0 citations62
US11014909B2May 25, 2021

Heteroaromatic compounds and their use as dopamine D1 ligands

PFIZER0 citations62
US9751877B2Sep 5, 2017

Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders

PFIZER1 citations60
US9067934B2Jun 30, 2015

Bicyclic pyridinones

PFIZER2 citations59
US9850232B2Dec 26, 2017

Heteroaromatic compounds and their use as dopamine D1 ligands

PFIZER1 citations52
US9745317B2Aug 29, 2017

Heterocyclic compounds and their use as dopamine D1 ligands

PFIZER1 citations52
US10696658B2Jun 30, 2020

Heteroaromatic compounds and their use as dopamine D1 ligands

PFIZER0 citations51
US9193726B2Nov 24, 2015

Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders

PFIZER1 citations50
US9764040B2Sep 19, 2017

Spliceostatin analogs and methods for their preparation

PFIZER0 citations48
US10316021B2Jun 11, 2019

Heteroarylphenoxy benzamide kappa opioid ligands

PFIZER0 citations35

PETTERSSON MARTIN YOUNGJIN

1 patent